Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes

International Journal of Infectious Diseases

Volumn 17, Issue 5, 2013, Pages

  Bordon, Jose ^a   Aliberti, Stefano ^b   Duvvuri, Padmaraj ^a   Wiemken, Timothy ^c   Peyrani, Paula ^c   Natividad, Inez ^a   Caceres Lara, Alfredo ^a   Delapenha, Robert ^d   Blasi, Francesco ^e   Ramirez, Julio ^c,f  

^a Providence Hospital Washington DC   (United States)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c University of Louisville School of Medicine   (United States)

^d SAMFORD UNIVERSITY   (United States)

^e UNIVERSITY OF MILAN   (Italy)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Community acquired pneumonia; Mortality; Outcomes; Time to first antibiotic dose

Indexed keywords

AGED; ANTIBIOTIC THERAPY; ARTERIAL PH; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PLEURA EFFUSION; PROPENSITY SCORE; RETROSPECTIVE STUDY; SURVIVOR; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA, BACTERIAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STANDARD OF CARE; TREATMENT OUTCOME;

EID: 84876090518     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.09.021     Document Type: Article

References (19)

1. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: final data for 2007. National vital statistics reports; Vol. 58, No. 19. Hyattsville, MD: National Center for Health Statistics; 2010. Available at: (accessed December 19, 2011). http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf.
2. Health, United States, 2010 with special feature on death and dying. CDC. Available at: (accessed December 19, 2011). http://www.cdc.gov/nchs/data/hus/hus10.pdf.
3. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl 2):S27-S72. Infectious Diseases Society of America; American Thoracic Society.
4. Pines J.M., Hollander J.E., Datner E.M., Metlay J.P. Pay for performance for antibiotic timing in pneumonia: caveat emptor. Jt Comm J Qual Patient Saf 2006, 32:531-535.
5. Welker J.A., Huston M., McCue J.D. Antibiotic timing and errors in diagnosing pneumonia. Arch Intern Med 2008, 168:351-356.
6. Houck P.M., Bratzler D.W., Nsa W., Bartlett J.G. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004, 164:637-644.
7. Meehan T.P., Fine M.J., Krumholz H.M., Scinto J.D., Galusha D.H., Mockalis J.T. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997, 278:2080-2084.
8. Bruns A.H., Oosterheert J.J., Hustinx W.N., Gaillard C.A., Hak E., Hoepelman A.I. Time for first antibiotic dose is not predictive for the early clinical failure of moderate-severe community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2009, 28:913-919.
9. Benenson R., Magalski A., Cavanaugh S., Williams E. Effects of a pneumonia clinical pathway on time to antibiotic treatment, length of stay, and mortality. Acad Emerg Med 1999, 6:1243-1248.
10. Silber S.H., Garrett C., Singh R., Sweeney A., Rosenberg C., Parachiv D., et al. Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia. Chest 2003, 124:1798-1804.
11. Marrie T.J., Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest. 2005, 127:1260-1270.
12. Community-Acquired Pneumonia Organization (CAPO). The CAPO cohort study. Louisville, KY: CAPO; Available at: (accessed December 19, 2011). http://www.caposite.com/.
13. Imai K., van Dyk D.A. Causal inference with general treatment regimens: generalizing the propensity score. J Am Stat Assoc 2004, 99:854-866.
14. Waterer G.W., Kessler L.A., Wunderink R.G. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest 2006, 130:11-15.
15. Yu K.T., Wyer P.C. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia. Ann Emerg Med 2008, 5:651-662.
16. Kanwar M., Brar N., Khatib R., Fakih M.G. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest 2007, 131:1865-1869.
17. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
18. Lim W.S., van der Eerden M.M., Laing R., Boersma W.G., Karalus N., Town G.I., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382.
19. Yende S., Angus D.C., Ali I.S., Somes G., Newman A.B., Bauer D., et al. Influence of comorbid conditions on long-term mortality after pneumonia in older people. J Am Geriatr Soc 2007, 55:518-525.